drugset / Trial / NCT03663374

Efficacy and Safety Evaluating Study of Odelepran for the Use in Patient With Alcohol Dependence

NCT03663374 ↗

Phase 3 Completed 644 enrolled R-Pharm Synergy Research Group · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study was to assess efficacy and safety of the study drug Odelepran, 125 mg as compared to placebo in the treatment of alcohol dependence in adult outpatients.

Timeline

Start
2014-11-18
Primary completion
2016-04-16
Completion
2016-05-14

Publications

  • Background Sobell L.C., Sobell M.B. (1992) Timeline Follow-Back. In: Litten R.Z., Allen J.P. (eds) Measuring Alcohol Consumption. Humana Press, Totowa, NJ

Drugs

EvaluationDrugModalityDoseRoute
Subject Odelepan Unknown 125 mg Oral

Indications